Stocks
IGM Biosciences (IGMS) EBITDA margin US GAAP (year values) |
|||||||||
| 2019 | 2020 | 2021 | 2022 | 2023 | LTM ? | CAGR 5 years ? | |||
| EBITDA margin, % | ? | -21 324% | -11 980% | -11 857% | |||||
| Changes by years, y/y, % | +9 344pp | -43.8% | |||||||
IGM Biosciences. EBITDA margin, %
IGM Biosciences. EBITDA margin, changes, pp
IGM Biosciences (IGMS) EBITDA margin US GAAP (quarter values) |
||||||||
| 2023Q1 | 2023Q2 | 2023Q3 | 2023Q4 | 2024Q1 | LTM ? | |||
| EBITDA margin, % | ? | -11 822% | -14 740% | -13 116% | -9 668% | -10 836% | -11 857% | |
| Changes by years, y/y, % | +1 047pp | +4 710pp | +5 457pp | +986pp | ||||
| Changes by quarters, q/q, % | +3 303pp | -2 918pp | +1 624pp | +3 448pp | -1 168pp | |||
